Institutes outside Greece
Structural studies of the IAPP membrane-mediated aggregation pathway
Abstract
dc:descriptionAmyloid deposition in tissues is a common feature of several human diseases, including Parkinson’s disease, Huntington’s disease, and type II diabetes mellitus. In type II diabetes, amyloid deposition occurs in pancreatic β-cells and contains fibrillar islet amyloid polypeptide (IAPP) as a major component. In all amyloid diseases, a soluble protein undergoes misfolding and subsequently forms β-sheet-rich fibrillar aggregates. This aggregation process is multistep and nucleation-dependent, with several intermediate structural species preceding fibril formation. The causes of protein misfolding and the mechanisms underlying amyloid toxicity are not yet fully understood. However, increasing evidence suggests that oligomeric species contribute to β-cell toxicity through lipid membrane disruption. The role of lipid membranes in protein misfolding and aggregation pathways is increasingly recognized, as both accelerated aggregation and membrane disruption have been observed upon protein–lipid interactions. For IAPP, although the importance of lipid membranes in its aggregation pathway has been established, a detailed structural understanding of this interaction remains incomplete. As a first step toward elucidating the structural basis of the membrane-mediated IAPP aggregation pathway, we investigated the structure of monomeric IAPP upon membrane interaction using site-directed spin labeling. Our results show that membrane-bound IAPP adopts a single α-helical conformation spanning residues 9–22, while the N- and C-terminal regions remain less structured and do not form a well-defined secondary structure. In addition, we performed leakage assays to investigate membrane-disrupting properties of human IAPP, its analogs, and rat IAPP under different conditions. Membrane disruption depends on the concentration of negatively charged phospholipids. At high negative phospholipid content, both human and rat IAPP induce strong leakage. In contrast, at low negative phospholipid content, rat IAPP induces minimal leakage, whereas human IAPP remains active but with a more complex disruption mechanism. Finally, the expression and purification of a fusion protein (GB3-IAPP) are described. Efficient production of recombinant IAPP is essential for structural and biophysical studies of the peptide and will facilitate future investigations.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Apostolidou, Melania
- Αποστολίδου, Μελανία
Subjects
dc:subject × 15Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61555